DK0914129T3 - Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler - Google Patents

Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler

Info

Publication number: DK0914129T3
Authority: DK; Denmark
Prior art keywords: pct; aspirochlor; derivatives; immunosuppressive agents; sec
Prior art date: 1996-05-03

Application number

DK97921706T

Other languages

English (en)

Inventor

Khalid Islam

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-03

Filing date

1997-04-23

Publication date

2002-01-28

1997-04-23 Application filed by Lepetit Spa filed Critical Lepetit Spa

2002-01-28 Application granted granted Critical

2002-01-28 Publication of DK0914129T3 publication Critical patent/DK0914129T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK97921706T 1996-05-03 1997-04-23 Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler DK0914129T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96106991		1996-05-03
PCT/EP1997/002049 WO1997041862A1 (en)	1996-05-03	1997-04-23	Use of aspirochlorine or derivatives thereof as immunosuppressive agents

Publications (1)

Publication Number	Publication Date
DK0914129T3 true DK0914129T3 (da)	2002-01-28

Family

ID=8222742

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97921706T DK0914129T3 (da)	1996-05-03	1997-04-23	Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler

Country Status (13)

Country	Link
US (1)	US6133254A (da)
EP (1)	EP0914129B1 (da)
JP (1)	JP4287908B2 (da)
KR (1)	KR100439928B1 (da)
AT (1)	ATE209493T1 (da)
AU (1)	AU705290B2 (da)
CA (1)	CA2253635C (da)
DE (1)	DE69708645T2 (da)
DK (1)	DK0914129T3 (da)
ES (1)	ES2163763T3 (da)
IL (1)	IL126548A (da)
PT (1)	PT914129E (da)
WO (1)	WO1997041862A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007287928A (ja)	2006-04-17	2007-11-01	Nec Electronics Corp	半導体集積回路およびその製造方法ならびにマスク

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3991052A (en) *	1975-07-18	1976-11-09	Eli Lilly And Company	Antibiotic A-30641
US4001086A (en) *	1975-07-18	1977-01-04	Eli Lilly And Company	Antibiotic a-30641 and process for production thereof
JP3383718B2 (ja) *	1995-02-15	2003-03-04	ニチモウ株式会社	大豆蛋白を原料とした生成物の製造方法

1997
- 1997-04-23 KR KR10-1998-0708829A patent/KR100439928B1/ko not_active IP Right Cessation
- 1997-04-23 US US09/171,848 patent/US6133254A/en not_active Expired - Lifetime
- 1997-04-23 EP EP97921706A patent/EP0914129B1/en not_active Expired - Lifetime
- 1997-04-23 DK DK97921706T patent/DK0914129T3/da active
- 1997-04-23 JP JP53947397A patent/JP4287908B2/ja not_active Expired - Lifetime
- 1997-04-23 IL IL12654897A patent/IL126548A/en not_active IP Right Cessation
- 1997-04-23 ES ES97921706T patent/ES2163763T3/es not_active Expired - Lifetime
- 1997-04-23 DE DE69708645T patent/DE69708645T2/de not_active Expired - Lifetime
- 1997-04-23 PT PT97921706T patent/PT914129E/pt unknown
- 1997-04-23 CA CA002253635A patent/CA2253635C/en not_active Expired - Lifetime
- 1997-04-23 AT AT97921706T patent/ATE209493T1/de active
- 1997-04-23 WO PCT/EP1997/002049 patent/WO1997041862A1/en active IP Right Grant
- 1997-04-23 AU AU27684/97A patent/AU705290B2/en not_active Expired

Also Published As

Publication number	Publication date
ES2163763T3 (es)	2002-02-01
IL126548A (en)	2002-02-10
EP0914129B1 (en)	2001-11-28
AU705290B2 (en)	1999-05-20
DE69708645T2 (de)	2002-08-08
AU2768497A (en)	1997-11-26
US6133254A (en)	2000-10-17
DE69708645D1 (de)	2002-01-10
ATE209493T1 (de)	2001-12-15
CA2253635C (en)	2006-01-03
IL126548A0 (en)	1999-08-17
CA2253635A1 (en)	1997-11-13
JP4287908B2 (ja)	2009-07-01
WO1997041862A1 (en)	1997-11-13
KR20000010724A (ko)	2000-02-25
KR100439928B1 (ko)	2004-12-16
JP2000514403A (ja)	2000-10-31
EP0914129A1 (en)	1999-05-12
PT914129E (pt)	2002-04-29

Publication	Publication Date	Title
DK0865281T3 (da)	2002-07-29	Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
DE69621831D1 (de)	2002-07-18	Piperazinderivative als tachykinin antagonisten
DK0891187T3 (da)	2002-04-29	Anvendelse af tetrahydro-beta-carbolin-derivater som antimetastatiske midler
AR006390A1 (es)	1999-08-25	Derivados de lactama
DK0937074T3 (da)	2003-06-23	Benzonaphthyridiner som bronkiale terapeutiske midler
NO961377D0 (no)	1996-04-03	Distamycin A-analoger som antitumor eller antivirale midler
DK0712408T3 (da)	1999-07-12	Tropyl-7-azaindol-3-ylcarboxyamider som antihostemiddel
DK0941221T3 (da)	2003-06-10	Substituerede dihydrobenzofuraner som PDE-inhibitorer
AUPN952696A0 (en)	1996-05-23	New heterocyclic compounds
FI962261A (fi)	1997-12-01	N-bis- tai N-tris-((1,2-dikarboksyyli-etoksi)-etyyli)amiinijohdannaiset, niiden valmistus ja käyttö
SV1998000151A (es)	1999-07-05	Compuestos de triazina
IT1285777B1 (it)	1998-06-18	Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
AP2001002045A0 (en)	2001-03-31	FKBP inhibitors.
DK0914129T3 (da)	2002-01-28	Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler
MX9900914A (da)	1999-05-31
AU6991696A (en)	1997-04-01	3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
SE9700706D0 (sv)	1997-02-27	Process for the preparation of benzothiazoline compounds
DK0900218T3 (da)	2002-09-02	Heterocykliske forbindelser
DE69827614D1 (de)	2004-12-23	Chinoxalindionen
DK0970042T3 (da)	2002-04-29	5-hydroxymethyl-2-aminotetraliner som kardiovaskulære midler
TW346483B (en)	1998-12-01	Benzene derivatives
ECSP982785A (es)	1999-05-17	Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion